LMR Partners’s Bausch Health BHC Stock Holding History

LMR Partners’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,400,000	Closed	-$9.65M	–	1118
2022 Q3	$9.65M	Buy	+1,400,000	New	+$9.72M	0.18%	138

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $3.66B AUM 25.21% 1-Year Est. Return

LMR Partners's BHC Position: Q4 2024 in Review

LMR Partners sold out of Bausch Health (BHC) in Q4 2024, closing a stake of 400,000 shares — an estimated $3.26M sold.

LMR Partners first reported a position in BHC in Q4 2014 and held it in 11 quarters. The position peaked at $15.6M in Q1 2022. 225 funds tracked by Wall St. Rank hold BHC as of Q4 2024.

LMR Partners reported no remaining Bausch Health position as of Q4 2024 after selling out during the quarter.
LMR Partners sold 400,000 Bausch Health shares in Q4 2024, an estimated $3.26M.
LMR Partners first reported a position in Bausch Health in Q4 2014 and held it in 11 quarters.
LMR Partners's Bausch Health position peaked at $15.6M in Q1 2022.
225 funds tracked by Wall St. Rank held Bausch Health as of Q4 2024.

Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.